TB Vax ARM virtual meeting: Prioritizing TB R&D at the UNHLM on TB and beyond
With the United Nations High-Level Meeting (UNHLM) on TB just weeks away, the TB Vaccine Advocacy Roadmap (TB Vax ARM) will host a special meeting on TB research and development (R&D) advocacy in the run up to this milestone event.
Join the virtual meeting on 7 September 2023 to learn about recent advocacy efforts and explore key messages and next steps around TB R&D at the UNHLM.
During the session, the TB Vax ARM, Results Canada, RESULTS UK, and Global Health Advocates will present on recent TB R&D advocacy activities in preparation for the UNHLM. Each presentation will be followed by a short Q&A.
- Investment Toolbox to Advance TB Vaccine Development through Joint Action (T20 Policy Brief) – Shaun Palmer, TB Vax ARM
- Accountability to End TB: A Global Responsibility (report) – Sahera Ramzan, RESULTS UK
- #YesWeCanEndTB with new investments in TB R&D and an open letter to CEPI to include bacterial pathogens and TB in their 100 day mission (campaigns) – Leigh Raithby, Results Canada
- Increasing funding for TB R&D in 2023, an emergency (position paper) – Global Health Advocates
Register for the meeting here.
The TB Vax ARM is a global coalition of TB stakeholders, including TB survivors, civil society organizations, and non-profits, invested in TB vaccine advocacy and research, and seeks to provide coordinated advocacy efforts that are complementary to ongoing TB vaccine R&D and policy efforts. The TB Vax ARM holds regular advocacy meetings with partners from across the world.
